NCT00382993 · Interventional trial
A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 2 of 2)
Overall registry status Completed
Phase 3
Conditions Migraine Disorders
Delaware Valley sites
- GSK Investigational Site · Philadelphia, PA · Philadelphia County
- GSK Investigational Site · Stratford, NJ · Camden County
First posted
Registry updated
Added to the directory